FRIDAY, June 21, 2024 -- An experimental cancer treatment regimen is achieving full remissions in some patients with aggressive B-cell lymphoma,...

Researchers from the University of Helsinki and HUS investigated the effects of recurring mutations in the KLHL6 gene in diffuse large B-cell...

THURSDAY, June 20, 2024 -- For patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with...

Society of Nuclear Medicine and Molecular Imaging Annual Meeting Cleveland Clinic researchers have discovered a new location for a protein that helps...

Regeneron (REGN) gets positive CHMP recommendation for odronextamab for the treatment of adults with relapsed/refractory follicular lymphoma or...

Researchers have found that longer-lasting heat waves can be deadlier and can pose unique health risks.

The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for using radiation therapy...

Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...

With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at Case Western...

WEDNESDAY, June 26, 2024 -- Glofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) is superior to rituximab (R)-GemOx for relapsed/refractory...